Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been promoted to Vice President, Finance and Controller...
* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11 /PRNewswire-FirstCall/ -- Biovail Corporation (TSX, NYSE:...
RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin...
Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Conn...
Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The November 21, 2003 edition of the Wall Street Journal...
Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial Reporting COLCHESTER, Conn., Nov. 21 /PRNewswire/...
/ C O R R E C T I O N -- Scott + Scott, LLC / In the news release, Scott + Scott, LLC Files Securities Lawsuit Against Biovail (NYSE: BVF; TSX: BVF), issued earlier today by Scott + Scott, LLC, we...
Scott + Scott, LLC Files Securities Lawsuit Against Biovail Pharmaceutical Company Targeted For Accounting Problems COLCHESTER, Conn., Nov. 14 /PRNewswire/ -- Scott + Scott...
Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others HARTFORD, Conn., Nov. 13 /PRNewswire/ -- A lawsuit seeking class action status has been filed in the...
Biovail Reports Third Quarter 2003 Financial Results - Correction - Total revenue increased 3% for Q3 2003 versus Q3 2002 - - Total revenues increase 14% for the nine month 2003 period versus the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.59 | 7.77441033074 | 7.589 | 8.179 | 7.501 | 420 | 7.9048901 | DE |
| 4 | -0.878 | -9.69415921387 | 9.057 | 9.36 | 7.501 | 700 | 8.50527838 | DE |
| 12 | 2.449 | 42.739965096 | 5.73 | 9.36 | 5.67 | 811 | 7.66564686 | DE |
| 26 | 2.045 | 33.3387675253 | 6.134 | 9.36 | 3.7235 | 1524 | 6.0153421 | DE |
| 52 | 1.51 | 22.6420752737 | 6.669 | 9.893 | 3.7235 | 1339 | 6.96080213 | DE |
| 156 | 0.395 | 5.07451181912 | 7.784 | 9.893 | 3.7235 | 1245 | 6.93555221 | DE |
| 260 | 0.395 | 5.07451181912 | 7.784 | 9.893 | 3.7235 | 1245 | 6.93555221 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
